Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice
about
Lessons from mouse models of high-fat diet-induced NAFLDWhite adipose tissue reference network: a knowledge resource for exploring health-relevant relationsNetwork signatures link hepatic effects of anti-diabetic interventions with systemic disease parametersA casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.Switching back to normal diet following high-fat diet feeding reduces cardiac vulnerability to ischaemia and reperfusion injury.TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetesReduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice.Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia.Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis.
P2860
Q26829532-8C81286E-D56B-4962-81D0-DCEA84C27357Q28650540-A98550A2-B7C4-4BC1-A3BB-E4A52038DD2AQ28652238-1E733A0E-9B98-49EF-8C21-B34F3F376670Q33874197-735950AF-D2EF-45A1-9964-C48F18EA55E0Q34523876-1A872331-EFC7-4EAF-AC23-C524CE9A543CQ35189862-BEC6AB74-3648-4614-B38D-CC0D0C670F2AQ35725816-D93966D0-0A0F-49B2-AC5A-5943E57B0E73Q36021450-738B3A5E-28E6-4660-B293-40590A9B4EE5Q37193179-8A4404BF-37BA-427F-8B62-06E035F8D04EQ38951126-CB180800-B3CC-4963-8225-F3B749F0F43EQ40764658-6783BEA4-E143-41D2-AC2B-52F67CB07E4CQ41195209-3CDEF62E-A3E9-4FDB-9393-CE297D0F50F2Q44437504-3B9711F3-010F-4D31-81A2-066B5872953A
P2860
Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@ast
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@en
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@nl
type
label
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@ast
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@en
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@nl
prefLabel
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@ast
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@en
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@nl
P2093
P2860
P50
P3181
P1433
P1476
Differential effects of drug i ...... ology analysis in LDLr-/- mice
@en
P2093
Ben van Ommen
Bianca van der Werff van der Vat
Johanna H M Stroeve
Karin Toet
Lars Verschuren
Marijana Radonjic
Nicole Cnubben
Peter Y Wielinga
Robert Kleemann
Suzan Wopereis
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0056122
P407
P577
2013-01-01T00:00:00Z